Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates

Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates

Submitted by admin on April 23, 2024 - 9:46pm
Source: 
BioSpace
News Tags: 
Incyte
M&A
Escient Pharma
atopic dermatitis
Headline: 
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
snippet: 

Incyte announced Tuesday that it is buying Escient Pharmaceuticals for $750 million to gain control of a pipeline led by clinical-phase treatments of atopic dermatitis and other skin conditions.

Do Not Allow Advertisers to Use My Personal information